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Abstract
The GTPase superfamily of proteins provides molecular switches to regulate numerous cellular 
processes. The ‘GTPase switch’ paradigm, in which external regulatory factors control the switch 
of a GTPase between ‘on’ and ‘off’ states, has been used to interpret the regulatory mechanism of 
many GTPases. However, recent work unveiled a class of nucleotide hydrolases that do not adhere 
to this classical paradigm. Instead, they use nucleotide-dependent dimerization cycles to regulate 
key cellular processes. Here, we summarize recent studies of dimeric GTPases and ATPases 
involved in intracellular protein targeting. We suggest that these proteins can use the 
conformational plasticity at their dimer interface to generate multiple points of regulation, thereby 
providing the driving force and spatiotemporal coordination of complex cellular pathways.
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A class of unconventional, dimerization-activated GTPases
Guanosine-triphosphate (GTP) binding proteins, or GTPases, are a superfamily of proteins 
that regulate numerous cellular pathways[1–4]. Pioneering work on the extended Ras 
subfamily of GTPases, exemplified by Ras, Rho, Rab, Arf and heterotrimeric GTPases, has 
established a ‘GTPase switch’ paradigm to explain their regulatory mechanism[5, 6]. In this 
paradigm, a GTPase alternates between a GDP-bound inactive conformation and a GTP-
bound active conformation in which they interact with effector molecules to trigger cellular 
responses. A key to this mechanism is the temporal separation of the GTP- and GDP-states 
in these proteins due to their intrinsically slow rates of nucleotide exchange and GTP 
hydrolysis. Thus, inter-conversion between these states requires the recruitment of external 
factors, such as guanine nucleotide exchange factors (GEFs) and GTPase activating proteins 
(GAPs), to turn these GTPases ‘on’ and ‘off’, respectively. Additional layers of regulation 
can be exerted, such as through Guanine nucleotide dissociation inhibitors that further 
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stabilize the GDP-state[7]. Nevertheless, these mechanisms are conceptually extensions of 
the bi-modal regulatory mechanism established by the classic paradigm.
Despite the importance of Ras-type GTPases, analyses of the evolutionary history of the P-
loop GTPases and related ATPases suggested a much larger repertoire of proteins that use 
the energy from nucleotide triphosphates to regulate cellular processes (Figure 1)[8]. As 
shown by Leipe et al[8], the GTPase superclass underwent seven evolutionary 
diversifications after the ancestral GTPase (Figure 1, yellow circles) and can be divided into 
two large classes. The TRAFAC (after translation factors) class includes proteins involved in 
translation, signal transduction and cell motility. The SIMIBI (after signal recognition 
particle (SRP), MinD, and BioD) class includes the SRP54 and SRP receptor (SR) GTPases 
and MinD-like ATPases involved in protein localization, chromosome partitioning and 
membrane transport. Notably, the extended Ras subfamily is a small subset of GTPases in 
the TRAFAC class that emerged after the last evolutionary diversification (Figure 1, blue). 
Compared to Ras-type GTPases, the SIMIBI class of nucleotide hydrolases displays distinct 
biochemical, structural and dynamic properties, and their regulatory mechanisms are far less 
understood.
A notable feature of the SIMIBI class of GTPases and related ATPases is their ability to 
form dimers (Fig. 1A, red and Figs. 1B–H). As proposed by Gasper et al, many G proteins 
are activated by nucleotide-dependent dimerization and can be functionally grouped into a 
class that uses regulatory mechanisms distinct from the ‘GTPase switch’ paradigm[9]. 
Readers are referred to the reviews by Gasper et al[9] for a more comprehensive summary of 
G protein systems (within and beyond the SIMIBI family) that might fall into this class, and 
Bange et al[10] for a detailed description of the structural features of the SIMIBI family 
GTPases. A major gap in understanding has been the mechanism by which the dimerization-
governed nucleotide hydrolase cycles of these proteins are coupled to biological function. 
Here, we summarize recent findings from two of the best-characterized systems, the SRP/SR 
GTPase dimer and the Get3 ATPase dimer, which mediate the co- and post-translational 
targeting of nascent proteins to cellular membranes, respectively. The results show that these 
proteins not only function as dimers but also generate multiple, functionally and structurally 
distinct conformational states in the dimer in an ordered sequence (hence the analogy to 
‘tango’ as originally coined by Gasper et al). Each state provides a point of regulation and/or 
fulfills a distinct function in the respective biological pathway. These observations suggest a 
novel mode of regulation that might be generalized to this class of dimeric nucleotide 
hydrolases.
The SRP/SR heterodimer: GTPase tangos drive co-translational protein 
targeting
SRP and SR mediate a universally conserved protein targeting pathway responsible for the 
delivery of 25–30% of newly synthesized proteome to the eukaryotic endoplasmic reticulum 
or the bacterial plasma membrane[11–13]. This process begins when a nascent membrane or 
secretory protein emerges from a translating ribosome. These proteins carry hydrophobic 
signal sequences or transmembrane domains (TMDs) near the N terminus that are 
Shan Page 2
Trends Biochem Sci. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
recognized, together with the ribosome, by SRP. Via the interaction of SRP with SR, the 
ribosome•nascent chain complex (RNC) is delivered to the membrane. There, the RNC is 
transferred to the SecYEG (or Sec61p in eukaryotes) protein translocation channel, or 
translocon, which allows the nascent protein to integrate into or translocate across the 
membrane.
Efficient and accurate co-translational protein targeting requires spatial and temporal 
control, which is provided by the two highly homologous GTPases, SRP54 and SR (Figs. 1B 
and 2A). Both proteins contain a P-loop GTPase domain, termed the G-domain, which 
contains the GI–GIV sequence motifs conserved in most GTPases[14, 15]. In both proteins, 
an N-terminal four helix bundle termed the N-domain packs against the G-domain to form a 
structural and functional unit called the NG domain (Fig. 2A, top structures)[16, 17]. In 
addition to the NG-domain, SRP54 contains a methionine rich M-domain (Fig. 2A top, dark 
blue) that provides binding sites for the SRP RNA and for signal sequences or TMDs on the 
nascent polypeptide[18–20]. Bacterial SR has an acidic A-domain that mediates interactions 
with phospholipids[21, 22] and possibly with the SecYEG translocon[23]. Eukaryotic SR is 
anchored on the ER membrane via association of the SRα subunit (containing the NG-
domain) with SRβ, an integral membrane protein [22, 24–26].
Unlike the Ras-type GTPases, free SRP and SR do not exhibit significant conformational 
changes between the apo-, GDP-, and GTP-bound states[16, 17, 27–29]. Further, their NG-
domains contain wide-open nucleotide binding sites (Fig. 2, top panel)[16, 17], consistent 
with biochemical data showing that these GTPases exhibit weak nucleotide affinities and 
GDP-GTP exchange rates that are 104–106-fold faster than those of Ras-type GTPases[30–
33]. Thus, there is no need to recruit an external GEF to turn these GTPases to the ‘on’ state. 
Moreover, the GII motif, which contains multiple catalytic residues, is disordered and 
suboptimally aligned with the bound GTP in free SRP and SR, consistent with their low 
basal GTPase rates[33]. Notably, GTP hydrolysis is enhanced >104-fold when SRP and SR 
assemble a complex[33, 34]. Thus, there is also no need to recruit an external GAP to turn 
these GTPases to the ‘off’ state. These features strongly suggest that SRP and SR use a 
mode of regulation distinct from the classical GTPase switch paradigm.
A combination of molecular genetics, fluorescence spectroscopy and structural analyses, 
primarily focused on the bacterial SRP and SR, demonstrated that their GTPase cycle is 
instead driven by multiple conformational changes during SRP-SR dimerization, which 
culminates in reciprocal GTPase activation (Fig. 2A). Free SRP and SR are in an inactive 
‘open’ conformation suboptimal for binding one another (Fig. 2A, top)[33, 35, 36]. Their 
interaction begins with a transient ‘early’ intermediate, which is primarily stabilized by 
electrostatic attractions between their N-domains and by contacts of the GGAA tetraloop of 
the SRP RNA with a conserved lysine on the SR G-domain (Fig. 2A, right structure)[37–
39]. Subsequent rearrangements in both proteins, involving adjustments at the N-G domain 
interface, generate a stable ‘closed’ complex in which the G- and N-domains of SRP and SR 
together form an extensive interaction surface (Fig. 2A, bottom structure)[38, 40, 41]. The 
two GTP molecules also hydrogen bond across the dimer interface, further stabilizing the 
closed complex and conferring its specificity for GTP. Finally, cooperative rearrangements 
in the GII motifs of both proteins bring key catalytic residues into close contact with the two 
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bound GTP molecules, forming a composite active site at the dimer interface (Fig. 2A, step 
4)[40–42]. These movements of the GII motifs are coupled to an 100 Å movement of the 
SRP•SR NG-domain dimer from the tetraloop to the 5’, 3’-distal site of the SRP RNA, 
where a conserved cyanine base inserts into and further optimizes the GTPase active site to 
generate the ‘activated’ complex (Fig. 2A, left structure)[43–45]. Stimulated GTP hydrolysis 
then drives the disassembly and recycling of the complex (Fig. 2A, step 5).
Importantly, each conformational state in the SRP•SR dimer provides a distinct point of 
regulation at which these GTPases can directly sense and respond to different biological 
cues in the pathway. For example, assembly of a stable ‘closed’ complex between SRP and 
SR is intrinsically very slow (kon ~102–103 M−1s−1)[33, 36, 46], primarily due to the labile 
nature of the ‘early’ intermediate, >98% of which dissociates before it rearranges into the 
stable ‘closed’ complex[38]. However, RNCs bearing SRP substrates stabilize the ‘early’ 
intermediate >100-fold and thus accelerates assembly of the ‘closed’ complex up to 103-fold 
(Fig. 2A, steps 1–2)[47–49]. Rearrangement to the ‘closed’ state is further driven by the 
interaction of SR with anionic phospholipids (Fig. 2A, step 3)[50], allowing a stable 
RNC•SRP•SR ‘closed’ targeting complex to accumulate at the membrane. Finally, the last 
rearrangement that leads to GTPase activation is strongly inhibited by the RNC[48, 51]; this 
effect, termed ‘pausing’, is reversed when the targeting complex contacts the SecYEG 
translocon (Fig. 2A, step 4)[51, 52]. ‘Pausing’ serves two roles: (i) as a ‘timer’ that gives the 
targeting complex an extended time window to search for the SecYEG complex, minimizing 
premature GTP hydrolysis which would lead to abortive pathways; and (ii) as a spatial 
sensor that couples GTP hydrolysis to the successful unloading of cargo at the membrane 
translocon.
Collectively, these findings provide a high-resolution model for how the GTPase cycle in the 
SRP•SR dimer provides spatiotemporal coordination of co-translational protein targeting 
(Fig. 2B). SRP-SR interaction is minimized in the absence of cargo and is initiated only 
when SRP binds RNCs bearing SRP substrates (steps 1–2). Before engaging the membrane 
translocon, the RNC•SRP•SR complex is primarily in the ‘early’ conformational state in 
which the RNC is tightly bound to SRP, and GTP hydrolysis is delayed. Interactions of SR 
with phospholipids and with the SecYEG translocon induce GTPase rearrangements into the 
‘closed’ and ‘activated’ states, in which the SRP•SR NG-domain complex detaches from the 
ribosome exit site and moves to the distal site of the SRP RNA (steps 3–4). These 
rearrangements reduces the affinity of the SRP•SR complex for RNC over 30-fold and free 
up the ribosome exit site for subsequent docking onto the SecYEG translocon, initiating a 
sequential and coordinated cargo handover event[53] (step 5). The same rearrangement also 
activates GTP hydrolysis in the SRP•SR complex, driving their disassembly and recycling 
(step 5). Thus, each conformational change in the SRP•SR GTPase dimer allows it to 
communicate with the cargo, membrane, and translocon; these allosteric communications 
provide the driving force for the targeting pathway and have also been shown to generate 
fidelity checkpoints to enhance the accuracy of substrate selection by SRP[37, 49, 54].
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The Get3 homodimer: ATPase tangos drive post-translational protein 
targeting
Get3 (or TRC40 in mammalian cells) belongs to the ArsA subfamily of ATPases, 
represented by the arsenic-translocating ATPase ArsA (Fig. 1A). Recent biochemical and 
genetic analyses showed that in eukaryotic cells, Get3 (and TRC40) mediates the delivery of 
an essential class of membrane proteins, termed tail-anchored (TA) proteins as their sole 
TMD resides near the C terminus, to the ER [55–58]. This process, termed the Guided-
Entry-of-Tail-Anchored proteins (GET) pathway, begins with the co-chaperone Sgt2 that 
captures TA proteins released from the ribosome[57]. TA proteins are then transferred from 
Sgt2 to Get3, bridged by a scaffolding complex consisted of Get4 and Get5 subunits[57]. A 
receptor complex on the ER membrane, comprising Get1 and Get2 subunits, captures the 
Get3•TA complex and drives the dissociation of TA proteins from Get3 and its insertion into 
the membrane[58–61].
Initial structural and biochemical work showed that Get3 forms an obligate dimer whose 
conformation is regulated by the bound nucleotide. Analogous to SRP and SR, Get3 
contains a P-loop nucleotide hydrolase domain in which the bound ATPs face one another at 
the dimer interface (Fig. 3A, top right structure)[62–64]. Also analogous to the SRP and SR 
NG-domains, the ATPase domain of Get3 is structurally and functionally coupled to a 
helical domain (Fig. 3A, top structures). Nucleotide binding adjusts the Get3 dimer 
interface, which is amplified into larger movements of its helical domains. This leads to 
various conformations, from more ‘open’ states in apo-Get3 in which the helical domains 
are separated, to more ‘closed’ states in Get3 bound to non-hydrolyzable ATP analogues, 
such as AMPPNP- and ADP•AlF4−, in which the helical domains are close together (Fig. 
3A, step 1)[62–64]. Importantly, multiple hydrophobic residues in the helical domains are 
brought into a contiguous groove in the ‘closed’ Get3 structure, and this site has been shown 
to mediate TMD binding[62, 65]. In contrast to ATP analogues, the Get1 cytosolic domain 
preferentially binds apo-Get3 in a wide-open conformation (Fig. 3A, top left structure) and 
promotes the release of TA substrate from Get3[59, 66].
Kinetic analyses of the Get3 ATPase cycle uncovered additional conformational states. The 
Get4/5 complex specifically stabilizes ATP binding to Get3[67]. Consistent with this, 
crystallographic analyses showed that Get4/5 bridges the dimer interface of ATP-bound 
Get3 and selectively stabilizes the latter into one of the most closed conformations 
observed[68, 69]. Nevertheless, Get4/5 inhibits ATP hydrolysis by Get3, indicating that 
Get4/5 induces a distinct ‘occluded’ state of Get3 in which tight and specific ATP binding is 
uncoupled from ATPase activation (Fig. 3A, step 3)[67]. In contrast to Get4/5, the TA 
substrate strongly activates the ATPase activity of Get3, indicating that TA-loaded Get3 
adopts an ‘activated’ conformation in which its active site is optimized (Fig. 3A, step 4)[67]. 
Compared to free Get3, TA-loaded Get3 also exhibits significantly weakened affinity for 
Get4/5[70], further supporting the notion that Get3 adopts a conformation distinct from the 
‘closed’ or ‘occluded’ states upon substrate loading. Finally, while nucleotide-bound 
Get3•TA complexes exhibit higher affinity for the Get2 than Get1 subunit (Fig. 3A, step 5), 
Get1 gains significantly higher affinity for the Get3•TA complex upon ADP release[70]. 
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This suggests another ‘strained’ conformation of the Get3•TA complex (although this could 
also be explained by a shift in conformational equilibrium of the Get3•TA complex towards 
the open conformation, rather than a distinct conformational statea), at which stage Get1 can 
initiate interaction with and remodeling of the targeting complex (Fig. 3A, step 6). Finally, 
Get1 exhibits the highest affinity for free, apo-Get3, with dissociation rate constants in the 
low nanomolar range[63, 70]; these results, combined with the crystal structures, strongly 
suggest that a wide-open Get3 bound to Get1 accumulates at the end of the targeting cycle.
Together, these results showed that the GET pathway is driven by an ordered series of 
nucleotide-, substrate-, and effector-driven conformational changes in the Get3 ATPase 
dimer (Fig. 3B). Prior to TA binding, the majority of Get3 in the cytosol is loaded with ATP 
and tightly bound to Get4/5 (steps 1–2). Get4/5 brings Get3 into the vicinity of Sgt2 (step 0) 
and induces Get3 into the optimal conformation and nucleotide state to capture the TA 
substrate. TA loading drives the dissociation of Get3 from Get4/5 and activates a rapid round 
of ATP hydrolysis (step 3). The Get3•TA complex is likely initially captured by the Get2 
subunit at the ER membrane (step 4). ADP release allows the Get3•TA complex to explore 
additional conformations for which Get1 has higher affinity, and thus initiates the 
remodeling of the targeting complex (step 5). The strong preference of Get1 for wide-open 
Get3 drives the disassembly of the Get3•TA complex (step 5), followed by insertion of the 
TA substrate into the ER membrane that may be facilitated by the TMDs of the Get1/2 
receptor[61]. At the end of the pathway, Get3 is tightly bound to Get1/2, requiring both ATP 
and Get4/5 to release it from ER and re-initiate the targeting cycle (steps 1–2)[70].
Unlike the bacterial SRP pathway for which the energetics, kinetics, and structure of almost 
every intermediate have been characterized, multiple questions remain for the GET pathway 
(Fig. 3, ‘?’). First, the targeting pathway demands distinct activities of Get3 before and after 
substrate loading: prior to TA binding, Get3 must be ATP-bound and tightly bound to 
Get4/5; after TA loading, Get3 must hydrolyze ATP and detach from Get4/5 so that it can 
instead interact with the Get1/2 receptor at the ER. Although a structure of Get3•TA peptide 
complex is now available, the conformation of Get3 in this structure is similar to that in the 
Get3•Get4/5 complex; it is unclear how the TA substrate drives the transition of Get3 from 
Get4/5 to the Get1/2 receptors. In addition, the structures of important intermediates in the 
pathway, such as Get2 and/or Get1 bound to the Get3•TA complex, are still unavailable, and 
the mechanisms by which Get1/2 remodels the Get3•TA complex and inserts the TA into the 
membrane remain unclear. Further, the structural basis for regulation of Get3’s ATPase 
activity by Get4/5 and the TA substrate remain to be elucidated. Finally, it is unclear whether 
additional upstream components are required to help load newly synthesized TA proteins 
onto Sgt2, and if so, how these substrate relay events are accomplished.
Comparison of SRP•SR with Get3: common regulatory principles?
Although the details of the SRP and GET pathways differ significantly, many similarities 
between the Get3 ATPase dimer and the SRP•SR GTPase dimer emerge from available data. 
In contrast to the classical ‘GTPase switch’ paradigm, both SRP and GET systems forego 
the use of nucleotide exchange and the recruitment of external GEFs and GAPs as major 
regulatory elements. In support of the initial proposal by Gasper et al, both systems use 
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dimers as the functional unit[9]. Further, multiple ‘on’ states can be generated within the 
dimer. Both the SRP•SR GTPase dimer and Get3 ATPase dimer undergo an ordered series of 
conformational changes on the global (open → closed transitions) and local (catalytic loop 
adjustments) scale to generate multiple, discrete functional states during their NTPase cycle. 
Each rearrangement provides a distinct regulatory point at which SRP•SR or Get3 can 
directly communicate with upstream and downstream effector molecules in the pathway. I 
suggest that these dimeric nucleotide hydrolases provide ‘multi-state navigator’ systems that 
use their conformational plasticity to ensure the spatiotemporal accuracy of diverse 
molecular actions required for cellular pathways.
What drove the evolution of these regulatory proteins? To answer this question, it is useful to 
reflect on the bi-modal nature of the classic ‘GTPase switch’, Ras-type GTPases often have 
a well-defined ‘on’ state in which they interact with effector molecules. In contrast, it is 
difficult to define a single ‘on’ or ‘off’ state for SRP•SR and Get3, as the pathways mediated 
by these proteins require a complex series of molecular events for which different functions 
must be turned ‘on’ or ‘off’ at distinct stages. For example, SRP and Get3 must effectively 
capture cargo proteins in the cytosol but promptly release them at the target membrane. SRP 
and SR must efficiently assemble a complex at early stages of targeting but promptly 
dissociate at the end of the targeting cycle. Effector interactions for Get3 is particularly 
complex, as this ATPase must bind three effector proteins, Get4, Get2 and Get1, in an 
ordered cascade[70]. The ability of SRP•SR and Get3 to adopt multiple conformations is 
necessary to drive these cyclic processes during which the substrate and various effector 
molecules must bind and later release in a sequential and controlled manner. Probably, 
modulation of the dimer interface provides a facile mechanism to increase conformational 
diversity, which might be particularly suitable for generating a multitude of conformational 
states required by these processes.
A second feature of the Ras-type GTPases is that their ‘on’ and ‘off’ states are temporally 
and often spatially separated from one another. This feature is essential for GTPases 
mediating signaling and other processes that need to be kept ‘off’ until the arrival of 
signaling cues. The need to recruit extrinsic GEFs and GAPs – which involve transduction 
of environmental signals, negative or positive feedback control, or translocation of proteins 
to a different cellular compartment[71] – further impose this tight regulation. In contrast, the 
processes mediated by the SIMIBI family of GTPases and ATPases are often constitutive 
and must occur rapidly. For example, co-translational protein targeting must occur before the 
nascent polypeptide reaches a critical length, which imposes a time window of 3–6 seconds 
for SRP and SR to complete each targeting cycle[72, 73]. The ability of SRP•SR and Get3 to 
directly respond to effector molecules in their respective pathways without the need to 
recruit extrinsic regulatory factors may be especially beneficial for vectorial processes that 
must occur efficiently.
In conclusion, multiple members of the SIMIBI family GTPases and related ATPases couple 
nucleotide-dependent dimerization to their biological function. Recent work on the SRP•SR 
and Get3 systems suggest that these proteins can use the conformational plasticity at their 
dimer interface to directly communicate with upstream and downstream effectors, thus 
providing spatiotemporal control of complex cellular pathways. More work is needed to 
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decipher the molecular mechanisms of this family of nucleotide hydrolases and understand 
the chemical and biological logic for utilizing this class of regulatory GTPases.
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Outstanding Questions
• When, where, and how do nucleotide binding and hydrolysis events occur 
during the dimerization cycles of SIMIBI family proteins? What structural 
and dynamic features of these proteins control these molecular events?
• How are the dimerization-governed GTPase and ATPase cycles coupled to the 
biological pathways mediated by these proteins?
• Are the principles observed for the SRP•SR and Get3 dimers generalizable to 
the remainder of SIMIBI family proteins?
• What is the chemical and biological logic for employing this class of 
regulators?
• Did this regulatory strategy arise from convergent or divergent evolution?
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Trends Box
• The SIMIBI family of GTPases and related ATPases provides a notable 
exception to the classic ‘GTPase switch’ paradigm.
• Nucleotide-, cargo-, and membrane-driven conformational changes during the 
dimerization cycle of SRP and SRP receptor GTPases provide spatiotemporal 
control of co-translational protein targeting.
• Nucleotide-, substrate-, and effector-driven conformational changes in the 
Get3 ATPase dimer coordinate post-translational membrane protein targeting.
• Coupling of nucleotide-dependent dimerization to biological function may be 
a general feature for the SIMIBI family of nucleotide hydrolases.
• Dimerization-activated GTPases and related ATPases can use modulation of 
dimer interface to generate multiple regulatory points in a biological pathway. 
They may constitute a novel class of “multi-state” regulatory systems.
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Figure 1. 
Multiple members of the SIMIBI GTPase family form dimers. (A) Inferred evolutionary 
history of GTPase families; adapted from Figure 1 in Leipe et al[8]. Numbered circles 
indicate various evolutionary events associated with the diversification of GTPases. Broken 
lines denote uncertainty in the exact point of origin of the lineage. Dashed ellipses group the 
lineages from within which a new lineage potentially could have emerged. Members of the 
extended Ras subfamily are highlighted in blue, members of the SIMIBI family known to 
form dimers are highlighted in red. (B–H) Top view of the structures of dimeric GTPases 
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and ATPases in the SIMIBI family, including SRP54 and SR (B; 1RJ9), FlhG (C; 4RZ3), 
MinD (D; 3Q9I), NifH (E; 1N2C), Get3 (F; 2WOJ), HypB (G; 2HF8), and PurA (H; 
4M9D). The bound nucleotides are in spacefill.
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Figure 2. 
Conformational changes in the SRP•SR GTPase dimer regulate co-translational protein 
targeting. SRP54 and SR are in blue and green, respectively. T denotes GTP; D denotes 
GDP. (A) Cargo, membrane and translocon drive multiple rearrangements during SRP-SR 
dimerization, as described in the text. ‘⊥’ denotes the effect of RNC in delaying GTPase 
activation. Top panel: the crystal structures of free SRP54 (left; 1QZW) and the SR NG-
domain (right; 2Q9C). The SRP54 NG- and M-domains are in light and dark blue, 
respectively, the linker between the two domains is in grey, and the SRP RNA is in tan. The 
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bound GTP analogues are in spacefill. Right panel: cryo-EM model of the ‘early’ SRP•SR 
complex bound to RNC (2XKV); the RNC is not shown for clarity. Bottom panel: the crystal 
structure of the ‘closed’ SRP-SR NG-domain complex (1RJ9). Left panel: the crystal 
structure of the ‘activated’ complex (2XXA). (B) GTPase rearrangements in SRP and SR 
drive distinct molecular steps during targeting. The steps are numbered to be consistent with 
part (A). Step 1, RNC with a signal sequence (magenta) binds SRP. Step 2, RNC-loaded 
SRP forms a stabilized ‘early’ targeting complex with SR. Step 3, phospholipids drive 
rearrangement to the ‘closed’ state. Step 4, SecYEG drives rearrangement to the ‘activated’ 
state, which frees the ribosome for subsequent unloading. Step 5, the RNC is unloaded from 
SRP onto the SecYEG complex, and GTP hydrolysis drives the disassembly and recycling of 
SRP and SR.
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Figure 3. 
Conformational changes in the Get3 ATPase dimer drive the post-translational targeting of 
TA proteins. T denotes ATP; D denotes ADP. (A) Nucleotide-, substrate-, and effector-
driven conformational changes during the Get3 ATPase cycle, as described in the text. ‘⊥’ 
denotes the effect of Get4/5 in delaying ATPase activation. Top right panel: crystal structure 
of closed Get3 bound with ADP•AlF4− (2WOJ). The two Get3 subunits in the dimer are in 
blue and tan, respectively. The bound nucleotides are in spacefill. Right panel: crystal 
structure of Get4/5- and ATP-bound Get3 (4PWX). Bottom panel: crystal structure of Get3 
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bound with ADP•AlF4− and a TA peptide (4XTR). Top left panel: crystal structure of a wide 
‘open’ Get3 bound to the Get1 cytosolic domain (3SJB). (B) ATPase rearrangements in Get3 
drive distinct molecular steps during TA protein targeting. The steps are numbered to be 
consistent with part (A). Get4/5 bridges between Sgt2 and Get3, and primes Get3 into the 
optimal conformation and nucleotide state for TA loading (step 0). TA binding drives Get3 
dissociation from Get4/5 (step 3) and activates ATP hydrolysis (step 4). The Get3•TA 
complex is probably captured by Get2 at the ER membrane (step 4). ADP release initiates 
interaction of the Get3•TA complex with Get1 (step 5), which drives disassembly of TA 
from Get3 (steps 6). Finally, ATP together with Get4/5 displace Get3 from Get1 and 
reinitiate the cycle (steps 1–2).
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